Anshika Jain
Clinical reasoning is fundamentally a multi modal process. Physicians rarely make important diagnostic or therapeutic decisions using a single source of information. Instead, they combine medical images, laboratory findings, medications, vital signs, previous diagnoses, genetic information, pathology reports, patient histories, and clinical narratives to construct an understanding of disease. The growing digitization of healthcare has generated enormous quantities of such heterogeneous data, creating both an opportunity and a challenge for artificial intelligence (AI). Conventional AI systems have generally been designed to analyze one modality at a time, such as an image, an electronic health record (EHR), or a genomic sequence. Multimodal artificial intelligence seeks to overcome this limitation by integrating several forms of clinical information within a unified computational framework.
Multimodal AI is particularly relevant to clinical reasoning because disease is not expressed through a single data type. A tumor may appear as a structural abnormality on an MRI scan, produce specific molecular alterations in genomic data, generate abnormal laboratory results, and be described through symptoms and observations in clinical notes. Considering these sources independently can fragment the clinical picture. By contrast, an appropriately designed multi modal system can identify relationships across modalities and provide clinicians with a more comprehensive representation of an individual patient. Recent research has therefore increasingly focused on combining imaging, EHR information, genomics, and clinical language to support diagnosis, prognosis, risk stratification, and personalized treatment.
The Evolution from Unimodal to Multimodal Clinical AI
The first major wave of medical AI focused primarily on individual tasks. Deep learning models demonstrated substantial capabilities in medical image classification, segmentation, detection, and prediction. Similar approaches were developed for structured EHR data, while natural language processing systems were designed to extract information from clinical documentation. Genomic AI, meanwhile, addressed tasks such as variant interpretation, disease-risk prediction, and molecular classification.
Although these developments have produced important advances, individual modalities provide only partial representations of a patient’s condition. An imaging model may detect a pulmonary lesion without understanding the patient’s smoking history, previous malignancies, genetic susceptibility, or current symptoms. Similarly, an EHR model may identify an increased risk of disease while lacking direct access to the anatomical information contained in an imaging study. Reviews of multi modal healthcare AI have consequently emphasized that clinical decision-making is inherently heterogeneous and requires the integration of multiple complementary data sources.
The emergence of large-scale foundation models, vision-language models, and multi modal architectures has accelerated this transition. Rather than building a separate model for every isolated clinical task, researchers are increasingly developing systems capable of representing and relating information from different modalities. Such models can potentially connect an image with a radiology report, a clinical narrative with laboratory findings, or a genomic alteration with a patient’s phenotype. This creates the possibility of AI systems that more closely resemble the information-integration process used in real clinical practice.
Medical Imaging as a Visual Source of Clinical Evidence
Medical imaging is one of the most important components of multi modal clinical reasoning. Radiography, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, positron emission tomography (PET), digital pathology, and other imaging technologies provide direct or indirect evidence about anatomical structures, physiological processes, and disease-associated changes.
AI has already demonstrated capabilities in detecting abnormalities, segmenting anatomical structures, quantifying lesions, and identifying imaging patterns. However, the clinical meaning of an imaging finding frequently depends on information outside the image itself. A pulmonary nodule, for example, may have very different clinical implications depending on the patient’s age, smoking exposure, previous cancer history, symptoms, laboratory results, and genetic characteristics.
Multimodal AI can address this contextual problem by combining visual representations with structured and unstructured clinical information. Imaging features can be integrated with demographic variables, laboratory measurements, diagnoses, medications, and clinical notes to generate a more patient-specific assessment. Research examining the fusion of EHR and imaging data has identified multiple strategies for combining these modalities, including early, intermediate, and late fusion approaches.
In oncology, the potential is particularly significant. Imaging can provide information about tumor size, location, morphology, and treatment response, while genomic information may characterize molecular alterations associated with tumor biology. Integrating these sources may allow AI systems to identify relationships between radiological phenotypes and molecular characteristics, supporting more individualized approaches to cancer diagnosis and treatment. Recent research has increasingly examined the integration of imaging with multi-omics and clinical information to create systems-level representations of cancer.
Electronic Health Records: The Longitudinal Clinical Context
EHRs provide a different type of information. Unlike a single image or laboratory test, an EHR can contain a longitudinal history of the patient’s health. Diagnoses, medications, laboratory results, procedures, vital signs, allergies, demographic characteristics, hospitalizations, and outcomes may accumulate over many years. Clinical notes can further document symptoms, physician observations, treatment decisions, and changes in the patient’s condition.
The longitudinal nature of EHR data is essential for clinical reasoning because many diseases evolve over time. A single measurement may have limited significance without knowing how it has changed. An elevated biomarker, for example, may be clinically meaningful when it represents a substantial change from a patient’s previous values but less concerning when it has remained stable for years.
AI systems can potentially model these temporal relationships and connect them with other modalities. Recent work on integrating genomic and EHR data emphasizes that EHRs contain longitudinal information about diagnoses, laboratory tests, procedures, and outcomes that can be combined with high-dimensional molecular data.
The challenge is that EHR data are highly heterogeneous. Some information is structured into standardized fields, while other information exists in free-text notes. Data may also be incomplete, inconsistently documented, or distributed across multiple healthcare institutions. Consequently, multi modal AI requires sophisticated methods for temporal modeling, data normalization, missing-data handling, and representation learning.
Genomics and the Molecular Dimension of Disease
Genomics introduces another level of information into clinical reasoning. Whereas imaging can reveal structural or functional manifestations of disease and EHRs describe clinical history, genomic data can provide information about biological predisposition and molecular mechanisms.
The integration of genomic data with clinical information is especially relevant to precision medicine. Genetic variants may influence disease susceptibility, prognosis, drug response, or tumor biology. However, genomic findings cannot always be interpreted independently. Their clinical significance may depend on the patient’s phenotype, family history, laboratory findings, pathology, imaging characteristics, and other molecular measurements.
AI provides methods for analyzing the high dimensionality and complexity of genomic information. Modern approaches can integrate genomic and multi-omics data with EHR-derived phenotypes to identify disease associations, biomarkers, and potentially clinically actionable patterns. A 2026 review in Nature Reviews Genetics highlights the increasing use of AI and machine learning for integrating genomic, multi-omics, and EHR data, while also emphasizing challenges related to standardization, data quality, and implementation.
The combination of genomics with imaging is another emerging area. In cancer care, for instance, imaging phenotypes may reflect underlying molecular processes. Linking radiological or pathological features with genomic signatures could help characterize disease heterogeneity and potentially support treatment selection. Such applications illustrate how multi modal AI can connect biological mechanisms with observable clinical manifestations.
Clinical Narratives and the Importance of Language
Clinical narratives contain information that is difficult to represent through structured databases alone. Physicians describe symptoms, disease progression, diagnostic reasoning, treatment responses, and uncertainties through free-text documentation. Patients themselves may provide important information through histories and symptom descriptions.
Natural language processing and large language models have significantly expanded the ability of AI systems to process this information. Modern clinical language models can summarize records, extract clinically relevant concepts, answer questions about documentation, and support decision-making workflows. Recent work on medical AI describes the growing role of clinical language models alongside vision-language models and multi modal health-record models.
In a multi modal clinical reasoning system, language can serve as a bridge between different information sources. A model could potentially examine an imaging study, interpret the accompanying radiology report, review previous clinical notes, identify relevant laboratory trends, and connect these observations with genomic findings.
However, clinical language is inherently complex. Notes may contain abbreviations, incomplete sentences, copied-forward information, uncertainty, contradictory observations, and institution-specific terminology. A multi modal AI system must therefore distinguish historical information from current findings and documented facts from clinical speculation. It must also preserve uncertainty rather than converting ambiguous documentation into apparently definitive conclusions.
Multimodal Fusion and Clinical Reasoning
The central technical challenge in multi modal AI is determining how different information sources should be combined. In early fusion approaches, information from different modalities is transformed into compatible representations and combined before prediction. Intermediate fusion methods allow each modality to develop specialized representations before integrating them through shared layers most important barriers. Medical institutions frequently use different EHR systems, terminology standards, imaging protocols, and laboratory conventions. Genomic datasets may also vary in sequencing technologies and annotation methods A model trained primarily on data from one population may not perform similarly in another. Recent reviews identify heterogeneous datasets, incomplete information, fairness disparities, and distribution shifts as continuing challenges. Late fusion approaches allow separate models to make predictions that are subsequently combined.
More advanced architectures use cross-modal attention, contrastive learning, vision-language representations, graph-based methods, and multi modal foundation models. These approaches attempt to learn relationships between modalities rather than simply concatenating their features. Recent surveys have described the evolution from conventional fusion strategies toward cross-modal representation learning, foundation-model architectures, and systems designed to function despite missing modalities.
This distinction is important for clinical reasoning. A useful system should not merely accumulate information; it should understand relationships between pieces of evidence. For example, it may need to recognize that a particular imaging abnormality corresponds to a documented clinical symptom and is biologically consistent with a specific molecular alteration. The ultimate objective is therefore not simply multi modal prediction but clinically meaningful evidence integration.
Applications Across Clinical Medicine
The potential applications of multi modal AI extend across numerous medical specialties. In oncology, multi modal systems can integrate imaging, pathology, genomic information, treatment history, and clinical narratives to support tumor characterization, prognosis, and treatment planning. The integration of multi-omics with imaging and clinical records is increasingly being explored as a way to understand the biological heterogeneity of cancer.
In neurology, multi modal systems can potentially combine MRI findings, neurological examination information, cognitive assessments, clinical narratives, and genomic data. This may be particularly valuable for complex disorders in which diagnosis depends on patterns distributed across multiple types of evidence.
Cardiology provides another important application. Imaging, electrocardiographic signals, laboratory measurements, medications, demographic information, and longitudinal EHR data can collectively describe cardiovascular risk and disease progression. Multimodal models could potentially use these complementary signals for risk assessment and clinical decision support.
Similar opportunities exist in ophthalmology, pulmonology, pathology, infectious disease, and emergency medicine. Across these fields, the fundamental principle remains the same: clinical conditions generate multiple forms of evidence, and AI systems that can integrate those forms may provide richer representations than systems restricted to a single modality.
Challenges in Clinical Implementation
Despite its promise, multi modal AI faces substantial technical and clinical challenges. Data interoperability is one of the most important barriers. Medical institutions frequently use different EHR systems, terminology standards, imaging protocols, and laboratory conventions. Genomic datasets may also vary in sequencing technologies and annotation methods. These differences can make it difficult to train models that generalize reliably across institutions.
Missing data represent another fundamental challenge. Not every patient undergoes genomic testing, advanced imaging, or extensive laboratory investigation. A system that requires every modality may therefore be unsuitable for real-world care. Robust multi modal architectures must be able to operate when one or more information sources are unavailable while appropriately communicating the resulting uncertainty.
Bias and fairness are equally important. Medical AI models can inherit biases from their training datasets, including differences in patient populations, healthcare access, imaging equipment, clinical documentation, and diagnostic practices. A model trained primarily on data from one population may not perform similarly in another. Recent reviews identify heterogeneous datasets, incomplete information, fairness disparities, and distribution shifts as continuing challenges for multi modal clinical AI.
Privacy and security are particularly important when genomic information and longitudinal health records are combined. Genomic data are highly sensitive and can have implications beyond the individual patient. Multimodal AI development therefore requires strong governance, secure data infrastructure, appropriate consent mechanisms, and careful consideration of data access and secondary use.
Interpretability, Uncertainty and Clinical Trust
Clinical adoption requires more than high predictive performance. Physicians need to understand why an AI system has produced a particular recommendation and what evidence contributed to it. This becomes more difficult as models incorporate increasingly complex combinations of images, genomic information, structured data, and clinical language.
Interpretability should therefore be treated as a central component of system design rather than an afterthought. A clinically useful multi modal system should ideally identify relevant evidence, distinguish high-confidence findings from uncertain interpretations, and allow clinicians to examine the underlying information. Recent literature emphasizes interpretability and uncertainty quantification as important requirements for translating multi modal AI into real-world clinical environments.
Importantly, multi modal AI should function as a clinical decision-support technology rather than an unquestioned replacement for professional judgment. Its role is to organize complex evidence, identify potentially relevant relationships, and toward systems that combine foundation models, clinical tools, heterogeneous datasets, and agentic workflows. A recent scoping review of multi modal AI agents identified applications in clinical decision support, documentation, monitoring, and medical education, while also noting assist clinicians in evaluating diagnostic and therapeutic possibilities. Human oversight remains essential, particularly when evidence is incomplete, contradictory, or outside the model’s validated domain.
The Future of Multimodal Clinical Reasoning
The next stage of multi modal AI is likely to involve increasingly integrated clinical foundation models capable of processing several types of information within a common framework. Current research is moving beyond isolated prediction tasks toward systems that combine foundation models, clinical tools, heterogeneous datasets, and agentic workflows. A recent scoping review of multi modal AI agents identified applications in clinical decision support, documentation, monitoring, and medical education, while also noting that clinical readiness remains an important area of investigation.
Future systems may operate across the entire clinical information environment. A physician could potentially provide a clinical question and receive an evidence-linked synthesis incorporating relevant imaging, longitudinal laboratory trends, medication history, clinical notes, pathology, and genomic findings. Rather than simply producing a prediction, the system could organize the evidence supporting different clinical hypotheses and identify missing information that may be relevant to further evaluation.
Such systems could also contribute to precision medicine by continuously updating patient representations as new information becomes available. A genomic result obtained months after an initial diagnosis, for example, could be integrated with previous imaging and clinical history to refine the understanding of disease. Similarly, a new imaging study could be interpreted in the context of longitudinal treatment response and molecular characteristics.
Conclusion
Multimodal AI represents an important evolution in medical artificial intelligence because it reflects the inherently multi modal nature of clinical reasoning. Medical images reveal anatomical and functional patterns, EHRs provide longitudinal clinical context, genomics offers molecular information, and clinical narratives capture symptoms, observations, decisions, and uncertainty. Integrating these sources can create a more comprehensive representation of individual patients than analyzing each modality independently.
The field nevertheless remains subject to major challenges involving interoperability, incomplete data, bias, privacy, interpretability, uncertainty, and generalization across healthcare environments. Evidence from recent research suggests substantial potential, but successful clinical translation will require rigorous validation, transparent evaluation, appropriate governance, and meaningful involvement of clinicians and patients.
Ultimately, the goal of multi modal clinical AI should not simply be to build larger or more technically sophisticated models. Its value will depend on whether these systems can transform heterogeneous biomedical information into reliable, understandable, and clinically relevant evidence. When appropriately developed and validated, multi modal AI could become an important component of clinical decision support, helping clinicians synthesize increasingly complex information while preserving human oversight and responsibility at the center of patient care.